New York, NY - WallStreetInvestorNews.com "Active Stocks to Watch for 09/27/12": Southridge Enterprises Inc. (PINKSHEETS:SRGE), Pristine Solutions Inc. (OTCQB: PRTN), Applied DNA Sciences Inc. (OTCQB: APDN),
MultiCell Technologies, Inc. (OTCQB: MCET)
Get the inside track and the latest Hot Tips with our Premium News Alerts that are FREE for a limited time http://www.wallstreetinvestornews.com or subscribe to our Youtube Channel (http://www.youtube.com/user/wallstreetinvestorne)
Thursday morning, after the market opened for trading, Southridge Enterprises Inc. (PINKSHEETS: SRGE) announced it has added the expertise of Mexican industry professionals Mr. Alejandro De Leon Garcia, Mr. Alfonso Sanchez Navarro and Mr. Salvador Martinez Moreno to its board of Directors.
“We are extremely fortunate to have these three gentlemen join the board of directors of Southridge, during this critical period of our Company’s development in Mexico. With over 45 years of combined experience, Mr. De Leon Garcia, Mr. Sanchez Navarro and Mr. Martinez Moreno will facilitate and expedite bringing our Gold & Silver mines into full production capacity,” said Michael Davies, President of Southridge.
In other recent developments, the Company has now engaged the necessary professional services to migrate and up-list the Company’s reporting status back to the Over-The-Counter Bulletin Board. It is anticipated that this process will be complete before the end of 2012.
Read the entire SRGE press release along with our full disclosure:
Get the inside track and the latest hot tips with our Premium News Alerts that are Free for a limited time;
Pristine Solutions, Inc. (OTCQB:PRTN) through its wholly-owned subsidiary company, Eaton Scientific Systems, Ltd., holds the intellectual property and global marketing rights to Tropine 3, a patent pending novel indication of an existing FDA approved drug for the non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women. The company is preparing for Phase 1 & 2 Clinical Trials with the goal of FDA approval of Tropine 3.
Applied DNA Sciences, Inc. (OTCQB:APDN) is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature(R) DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.
MultiCell Technologies, Inc. (OTCQB:MCET) is pleased to announce the acceptance by the American Society for Cell Biology (ASCB) of abstract "Short Synthetic Double Stranded RNA with Dual Activity - Oncolytic and Immune Modulatory - for Hepatocellular Carcinoma.".
Disclaimer: Wall Street Investor Communications Inc. (WSICI), also doing business as Wall Street Investor News, disseminates electronic information to subscribers through its network of affiliated companies and/or partners. WSICI is not a registered broker/dealer. WSICI is an advertising and marketing company, and as such may not sell, offer to sell or offer to buy any security. WSICI profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release may or may not have approved the statements made in this release and may or may not have approved the timing of this release. All statements and expressions are the sole opinion of WSICI and are subject to change without notice. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information, information supplied by third parties or WSICI’s own research. The accuracy or completeness of the information is not warranted and is only as reliable as the source from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. WSICI disclaims and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in securities of the companies’ discussed in this release is highly speculative and carries a high degree of risk. WSICI is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSICI profiled stocks.
This profile is not without bias, and is a paid release. To comply with Section 17(b) of the Securities Act of 1933, WSICI is disclosing that the company has been compensated for dissemination of this information on behalf of one or more of the companies mentioned in this release. For current services performed for Southridge Enterprises Inc. (SRGE:PINKSHEETS), WSICI has been compensated Fifty Thousand Dollars ($50,000.00), by third party Cameroon Marketing Advisors Inc., who is a non-affiliated and may hold a significant position in the stock.
FNM Disclosure: FN Media Group, LLC (FNMG) is a news dissemination & third party publishing service provider and is not affiliated or associated with any company or entity mentioned or listed herein. If you're a company interested in having FN Media Group assist you with creating a greater awareness for your next news release utilizing our multi-media and leading edge outreach solutions, contact us now at firstname.lastname@example.org. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as a recommendation or research material, nor an offer or solicitation to buy or sell securities. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made herein. For disseminating this release, FNMG was compensated one thousand dollars for distribution of this release.
WALL STREET INVESTOR COMMUNICATIONS, INC.
SOURCE: FN Media Group, LLC